Market Tracker

09/16 11:28am ET
13.23
Real-Time Quote
 -0.29 / -2.14%
Today’s Change
5.44
Today|||52-Week Range
18.80
+17.18%
Year-to-Date

Today’s Trading

Previous close13.52
Today’s open13.51
Day’s range13.25 - 13.73
Volume67,224
Average volume (3 months)337,335
Market cap$459.6M
Dividend yield--
Data as of 11:12am ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)+12.58%
Earnings growth (this year)-58.27%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)-73.43%
P/E ratioNM
Price/Sales201.53
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc-0.02-0.10%
RVNCRevance Therapeutics...+0.07+0.34%
ZFGNZafgen Inc-1.02-5.28%
XOMAXOMA Corp-0.09-2.11%
Data as of 11:27am ET, 09/16/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$1.6M
Annual profit (last year)-$39.8M
Net profit margin-2,487.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts